Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine in Advanced/Metastatic TCC of the Urothelium
NCT00101608Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2005
- Primary completion
- Apr 2007
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of vinflunine in transitional cell carcinoma of the urothelium (TCC), sponsored by Bristol Myers Squibb. Started Jan 2005; status: completed.
02
Drugs
vinflunine
03
Conditions
transitional cell carcinoma of the urothelium (TCC)
Beyond the preview
Go deeper on NCT00101608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101608.